Wellness testing empowers both the patient and their physician with accurate data to navigate their road to better health.
A comprehensive Hereditary Cancer Risk Assessment tool to uncover patient’s genetic predisposition.
A game-changing test designed to identify the right medication for the right patient.
Carrier screening allows each patient to identify how their personal genetic makeup may affect future family planning.
Non-invasive Prenatal Testing is designed to detect chromosomal abnormalities, with minimal risk to mom and baby.
Toxicology confirmations for drugs of abuse; perfect for treatment/abuse facilities.
1,200,000 ED Visits
According to the National Institute on Drug Abuse, 1.2 million emergency visits per year involve the non-medical use of pharmaceuticals. The most frequently reported drugs were opiate/opioid analgesics, present in 50 percent of the non-medical-use ED visits.
According to the FDA, 100,000 people die each year from adverse drug reactions. Acknowledging the impact pharmacogenomics can have on this death toll, the FDA now lists known genetic factors on packages of 137 of its approved medications.
$3.5 Billion in Costs
According to the CDC, adverse drug reactions cost the U.S. health system approximately $3.5 billion annually. The potential cost-savings of pharmacogenomic testing is a huge opportunity in healthcare today which could dramatically improve the quality and standard of care.
We Can Help
Personalized approaches to healthcare that incorporate screening and monitoring tools result in improved patient outcomes and long term cost lowering. Let our team design a custom solution for you today.